NO980420D0 - Anvendelse av griseofulvin for å inhibere cancervekst - Google Patents

Anvendelse av griseofulvin for å inhibere cancervekst

Info

Publication number
NO980420D0
NO980420D0 NO980420A NO980420A NO980420D0 NO 980420 D0 NO980420 D0 NO 980420D0 NO 980420 A NO980420 A NO 980420A NO 980420 A NO980420 A NO 980420A NO 980420 D0 NO980420 D0 NO 980420D0
Authority
NO
Norway
Prior art keywords
griseofulvin
cancer growth
inhibit cancer
inhibit
growth
Prior art date
Application number
NO980420A
Other languages
English (en)
Other versions
NO980420L (no
Inventor
James Berger Camden
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of NO980420D0 publication Critical patent/NO980420D0/no
Publication of NO980420L publication Critical patent/NO980420L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO980420A 1995-08-03 1998-01-30 Anvendelse av griseofulvin for å inhibere cancervekst NO980420L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US183995P 1995-08-03 1995-08-03
US67418196A 1996-07-16 1996-07-16
PCT/US1996/012475 WO1997005870A2 (en) 1995-08-03 1996-07-30 Use of griseofulvin for inhibiting the growth of cancers

Publications (2)

Publication Number Publication Date
NO980420D0 true NO980420D0 (no) 1998-01-30
NO980420L NO980420L (no) 1998-04-03

Family

ID=26669547

Family Applications (1)

Application Number Title Priority Date Filing Date
NO980420A NO980420L (no) 1995-08-03 1998-01-30 Anvendelse av griseofulvin for å inhibere cancervekst

Country Status (16)

Country Link
EP (1) EP0841914A2 (no)
JP (1) JPH11511136A (no)
KR (1) KR19990036137A (no)
AR (1) AR003176A1 (no)
AU (1) AU713031B2 (no)
BR (1) BR9609920A (no)
CA (1) CA2228503A1 (no)
CZ (1) CZ30598A3 (no)
HU (1) HUP9903506A3 (no)
IL (1) IL123094A0 (no)
MX (1) MX9800945A (no)
NO (1) NO980420L (no)
PL (1) PL324905A1 (no)
SK (1) SK14298A3 (no)
TR (1) TR199800244T2 (no)
WO (1) WO1997005870A2 (no)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6177460B1 (en) 1995-04-12 2001-01-23 The Procter & Gamble Company Method of treatment for cancer or viral infections
US6479526B1 (en) 1995-04-12 2002-11-12 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of viruses and cancers
US6262093B1 (en) 1995-04-12 2001-07-17 The Proctor & Gamble Company Methods of treating cancer with benzimidazoles
US6265427B1 (en) 1995-06-07 2001-07-24 The Proctor & Gamble Company Pharmaceutical composition for the method of treating leukemia
US5770616A (en) 1995-06-07 1998-06-23 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of cancers
US6686391B2 (en) 1995-08-04 2004-02-03 University Of Arizona Foundation N-chlorophenylcarbamate and N-chlorophenylthiocarbamate compositions
US5900429A (en) 1997-01-28 1999-05-04 The Procter & Gamble Company Method for inhibiting the growth of cancers
US6506783B1 (en) 1997-05-16 2003-01-14 The Procter & Gamble Company Cancer treatments and pharmaceutical compositions therefor
US6245789B1 (en) 1998-05-19 2001-06-12 The Procter & Gamble Company HIV and viral treatment
EP1098641B1 (en) * 1998-07-27 2016-04-27 St. Jude Pharmaceuticals, Inc. Chemically induced intracellular hyperthermia
KR20010103655A (ko) * 1998-11-09 2001-11-23 케네쓰 제이. 울코트 키메라 항-ｃｄ２０항체를 이용한 순환성 종양세포와관련된 혈액학적 악성종양의 치료법
US6423734B1 (en) 1999-08-13 2002-07-23 The Procter & Gamble Company Method of preventing cancer
US6608096B1 (en) 2000-09-26 2003-08-19 University Of Arizona Foundation Compounds and methods for use thereof in the treatment of cancer or viral infections
US6380232B1 (en) 2000-09-26 2002-04-30 The Procter & Gamble Company Benzimidazole urea derivatives, and pharmaceutical compositions and unit dosages thereof
US6462062B1 (en) 2000-09-26 2002-10-08 The Procter & Gamble Company Compounds and methods for use thereof in the treatment of cancer or viral infections
US6407105B1 (en) 2000-09-26 2002-06-18 The Procter & Gamble Company Compounds and methods for use thereof in the treatment of cancer or viral infections
CN101816794A (zh) * 2001-06-25 2010-09-01 味之素株式会社 抗肿瘤剂
EP2008652A1 (en) * 2007-06-28 2008-12-31 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Griseofulvin analogues for the treatment of cancer by inhibition of centrosomal clustering
EP2204367A1 (en) * 2008-12-22 2010-07-07 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Griseofulvin analogues for the treatment of cancer by inhibition of centrosomal clustering

Also Published As

Publication number Publication date
HUP9903506A2 (hu) 2000-06-28
PL324905A1 (en) 1998-06-22
HUP9903506A3 (en) 2000-07-28
EP0841914A2 (en) 1998-05-20
CA2228503A1 (en) 1997-02-20
CZ30598A3 (cs) 1998-06-17
KR19990036137A (ko) 1999-05-25
AU6683496A (en) 1997-03-05
TR199800244T2 (xx) 1998-09-21
BR9609920A (pt) 1999-07-06
NO980420L (no) 1998-04-03
IL123094A0 (en) 1998-09-24
MX9800945A (es) 1998-04-30
SK14298A3 (en) 1998-09-09
AU713031B2 (en) 1999-11-18
WO1997005870A2 (en) 1997-02-20
AR003176A1 (es) 1998-07-08
WO1997005870A3 (en) 1997-04-17
JPH11511136A (ja) 1999-09-28

Similar Documents

Publication Publication Date Title
NO980420D0 (no) Anvendelse av griseofulvin for å inhibere cancervekst
NO980473D0 (no) Anvendelse av flukonazol for å inhibere cancervekst
DE69630311D1 (de) Verminderung des haarwuchses
DE69617652D1 (de) Verminderung des haarwuchses
ZA961600B (en) Inhibition of hair growth
DE69427756D1 (de) Hemmung des haarwachstum
NO974701D0 (no) Syntese av tale-bölgeformer
HUP9801532A3 (en) Use of benzimidazole derivatives for producing pharmaceutical compositions for inhibiting the growth of cancers
NO980419D0 (no) Anvendelse av 1H,2,4-triazol derivater for å inhibere cancervekst
NO974693D0 (no) Farmasöytisk preparat inneholdende N-klorfenyl-karbamater, N-klorfenyltiokarbamater og N-fosfonoglycin-derivater for å inhibere vekst av cancer og virus i pattedyr
NO962491D0 (no) Orale formuleringer av S(+)-etodolac
NO980522L (no) En-sats syntese av 2-oksazolidinonderivater
PL321680A1 (en) Derivatives of proline useful as inhibitors of human leucocytes elastase
SG40869A1 (en) Use of pyrrole compounds as antifouling agents
AU2340397A (en) Use of nicotine to treat liver disease
NO973455D0 (no) Dermatologisk anvendelse av Vitamin-D-derivater
AU689887B2 (en) Oligonucleotides to inhibit the expression of isoprenyl protein transferases
NO976024D0 (no) Anvendelse av N-cykloheksylbenzamider for å behandle tarmlidelser
NO940190L (no) Anvendelse av alpha-ketoglutarat
DE69633529D1 (de) Bestimmung des Justierbits
NO972067D0 (no) Fremgangsmåte for å redusere kantkrölling av virer
AU2500997A (en) Use of prostaglandins to treat ataxia telangiectasia
NO980175D0 (no) Anvendelse av kationiske biopolymerer for å fremstille antiflassmidler
NO970127D0 (no) Topiske sammensetninger for behandling av hudsykdom
KR970003624U (ko) 처짐이 방지되는 모니터의 백커버

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application